Summary
To assess the relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses, symptoms and deterioration of cognitive function (12 cognitive tests) during progressive decreases in plasma glucose, and to quantitate glycaemic thresholds, 22 normal, non-diabetic subjects (11 males, 11 females) were studied on four occasions: prolonged fast (n=8, saline euglycaemia study, SA-EU), stepped hypoglycaemia (plasma glucose plateaus of 4.3, 3.7, 3 and 2.3 mmol/l) or euglycaemia during insulin infusion at 1 and 2 mU·kg−1·min−1 (n=22, high-insulin hypoglycaemia and euglycaemia studies, HI-INS-HYPO and HI-INS-EU, respectively), and stepped hypoglycaemia during infusion of insulin at 0.35 mU· kg−1·min−1 (n=9, low-insulin hypoglycaemia study, LO-INS-HYPO). Insulin per se (SA-EU vs HI-INS-EU), suppressed plasma glucagon (∼20%) and pancreatic polypeptide (∼30%), whereas it increased plasma noradrenaline (∼R10%, p<0.05). Hypoglycaemia per se (HI-INS-HYPO vs HI-INS-EU) induced responses of counterregulatory hormones (CR-HORM), symptoms and deteriorated cognitive function. With the exception of suppression of endogenous insulin secretion, which had the lowest glycaemic threshold of 4.44±0.06 mmol/l, pancreatic polypeptide, glucagon, growth hormone, adrenaline and cortisol had similar glycaemic thresholds (∼3.8-3.6 mmol/l); noradrenaline (3.1±0.0 mmol/l), autonomic (3.05±0.06 mmol/l) and neuroglycopenic (3.05±0.05 mmol/l) symptoms had higher thresholds. All 12 tests of cognitive function deteriorated at a glycaemic threshold of 2.45±0.06 mmol/l, but 7 out of 12 tests were already abnormal at a glycaemic threshold of 2.89±0.06 mmol/l. Although all CR-HORM had a similar glycaemic threshold, the lag time of response (the time required for a given parameter to increase) of glucagon (15±1 min) and growth hormone (14±3 min) was shorter than adrenaline (19±3 min) and cortisol (39±4 min) (p<0.05). With the exception of glucagon (which was suppressed) and noradrenaline (which was stimulated), insulin per se (HI-INS-HYPO vs LO-INS-HYPO) did not affect the responses of CR-HORM, and did not influence the symptoms or the cognitve function during hypoglycaemia. Despite lower responses of glucagon, adrenaline and growth hormone (but not thresholds) in females than males, females were less insulin sensitive than males during stepped hypoglycaemia.
Article PDF
Similar content being viewed by others
References
Schwartz N, Clutter W, Shah S, Cryer P (1987) Glycemic thresholds for activation of glucose counterregulatory systems are higher than the thresholds for symptoms. J Clin Invest 79: 777–781
De Feo P, Gallai V, Mazzotta G et al. (1988) Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man. J Clin Invest 82: 436–444
Mitrakou A, Ryan C, Veneman T et al. (1991) Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 260:E67-E74
Blackman JD, Towle VL, Lewis GF, Spire J-P, Polonsky KS (1990) Hypoglycemic thresholds for cognitive dysfunction in humans. Diabetes 39: 828–835
Amiel SA, Simonson DC, Tamborlane WV, De Fronzo R, Sherwin RS (1987) Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans. Diabetes 36: 518–522
Vea H, Jorde R, Sager G, Vaaler S, Sundsfjord J (1992) Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects. Diabetologia 35: 958–961
Diamond MP, Hallarman L, Starick-Zych K et al. (1991) Suppression of counterregulatory hormone response to hypoglycemia by insulin per se. J Clin Endocrinol Metab 72: 1388–1390
Liu D, Moberg E, Kollind M et al. (1991) A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man. J Clin Endocrinol Metab 73: 1123–1128
Liu D, Adamson U, Lins P-E, Kollind M, Moberg E, Andréasson K (1992) Inhibitory effect of circulating insulin on glucagon secretion during hypoglycaemia in type I diabetic patients. Diabetes Care 15: 59–65
Davis SN, Goldstein RE, Jacobs J et al. (1993) The effects of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycemia in normal humans. Diabetes 42: 263–272
Kerr D, Reza M, Smith N, Leatherdale BA (1991) Importance of insulin in subjective, cognitive, and hormonal responses to hypoglycemia in patients with IDDM. Diabetes 40: 1057–1062
Amiel S, Maran A, Powrie JK, Umpleby AM, Macdonald IA (1993) Gender differences in counterregulation to hypoglycaemia. Diabetologia 36: 460–464
Widom B, Kinsley BT, Simonson DC (1991) Women and men differ in counterregulatory hormone responses to hypoglycemia. Diabetes 40 [Suppl 1]: 543 A (Abstract)
Diamond MP, Jones TW, Caprio S et al. (1991) Gender: a determinant of the adrenergic response to hypoglycemia. Diabetes 40 [Suppl 1]: 27 A (Abstract)
Davis SN, Cherrington AD, Goldstein RE, Jacobs J, Price L (1993) Effects of insulin on the counterregulatory response to equivalent hypoglycemia in normal females. Am J Physiol 265:E680-E689
McGuire E, Helderman J, Tobin R, Andres R, Berman M (1976) Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41: 565–573
Andres R, Swerdloff T, Pozefsky T, Coleman D (1966) Manual feedback technique for the control of blood glucose concentration. In: Skeggs LT Jr (ed) Automation in analytical chemistry, Mediad, New York, pp 486–491
DeFeo P, Perriello G, DeCosmo Set al. (1986) Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans. Diabetes 35: 563–569
Boyle P, Schwartz N, Shah S et al. (1988) Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 318: 1487–1492
Fanelli C, De Feo P, Porcellati F et al. (1992) Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. J Clin Invest 89: 2005–2013
Kohn A, Annibale B, Suriano G et al. (1985) Gastric acid and pancreatic polypeptide responses to modified sham feeding: indication of an increased basal vagal tone in a subgroup of duodenal ulcer patients. Gut 26: 776–782
Zar J (1984) Biostatistical analysis. Prentice Hall, Englewood Cliffs
Cryer PE (1993) Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Physiol 264:E149-E155
Bolli GB (1990) From physiology of glucose counterregulation to prevention of hypoglycaemia in type 1 diabetes mellitus. Diab Nutr Metab 3: 333–349
Schwartz TW (1983) Pancreatic polypetide: a hormone under vagal control. Gastroenterology 85: 1411–1425
Mitrakou A, Mokan M, Ryan C, Veneman T, Cryer P, Gerich J (1993) Influence of plasma glucose rate of decrease on hierarchy of responses to hypoglycemia. J Clin Endocrinol Metab 76: 462–465
De Feo P, Perriello G, Torlone E et al. (1991) Evidence against important catecholamine compensation for absent glucagon counterregulation. Am J Physiol 260:E203-E212
De Feo P, Perriello G, Torlone E et al. (1991) The contribution of adrenergic mechanisms to glucose counterregulation in humans. Am J Physiol 261:E725-E736
De Feo P, Perriello G, Torlone E et al. (1989) Demonstration of a role for growth hormone in glucose counterregulation. Am J Physiol 256:E835-E843
De Feo P, Perriello G, Torlone E et al. (1989) Contribution of cortisol to glucose counterregulation in man. Am J Physiol 257:E35-E42
Gerich J, Mokan M, Veneman T et al. (1991) Hypoglycemia unawareness. Endo Rev 12: 356–371
Silverberg AB, Shah SD, Haymond MW, Cryer PE (1980) Norepinephrine: hormone and neurotransmitter in man. Am J Physiol 234:E252-E256
Shah SD, Tse TF, Clutter WE, Cryer PE (1984) The human sympathochromoaffin system. Am J Physiol 247:E380-E384
Davis SN, Collins L, Price L, Hedstrom C, Shawers C (1993) The effects of physiological insulinemia on the counterregulatory response to prolonged hypoglycemia in normal man. Diabetes 42 [Suppl 1]: 44 A (Abstract)
Bolli G, De Feo P, Perriello G et al. (1984) Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man: role of the beta-cell and arterial hyperinsulinemia. J Clin Invest 73: 917–922
Zandomegneghi R, Luciani A, Massari M et al. (1990) Interactions between endogenous and exogenous insulin and human pancreatic polypeptide secretion. Diab Metab 16: 21–25
Brunicardi FC, Druck P, Sun YS, Elahi D (1988) Regulation of pancreatic polypeptide secretion in the isolated perfused human pancreas. Am J Surg 155: 63–69
Porcellati F, Fanelli C, Bottini P et al. (1993) Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic subjects with and without autonomic neuropathy. Diabetes 42: 1055–1064
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fanelli, C., Pampanelli, S., Epifano, L. et al. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 37, 797–807 (1994). https://doi.org/10.1007/BF00404337
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00404337